Dr. Emad Dawoud

09:45 –10:30

Friday 3-5-2024 Day 1

Role of anthracyclines in early breast cancer

  • When to omit anthracyclines in(neo) adjuvant therapy of HER2-negative breast cancer

    When to use anthracyclines in (neo) adjuvant therapy of HER2-positive breast cancer

Moderator:Dr. Meteeb Alfohaidi



Saturday 4-5-2024 Day 2

Pancreatic cancer

  • Neoadjuvant therapy in resectable/borderline resectable pancreatic cancer
  • Best neoadjuvant strategy
  • 1st line and subsequent therapies in pancreatic cancer: Doublet vs Triplets
  • biomarkers for metastatic patients

Moderator: Dr. Abdullah Alsharm



Saturday 4-5-2024 Day 2

Challenges and dynamics of oncology health care

  • Financial toxicities and economic burden
  • Delayed access to oncology care
  • Cancer survivors: challenges and special requirements
  • Integration of service with primary health care for cancer survivors

Moderator: Dr. Esam Murshid